Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126635421 | 12663542 | 1 | I | 201607 | 20160812 | 20160818 | 20160818 | EXP | US-PFIZER INC-2016386700 | PFIZER | 80.00 | YR | M | Y | 73.00000 | KG | 20160818 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126635421 | 12663542 | 1 | PS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, 1X/DAY, ONE CAPSULSE | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | QD | ||||||
| 126635421 | 12663542 | 2 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | UNK | 0 | |||||||||||
| 126635421 | 12663542 | 3 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | UNK | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126635421 | 12663542 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126635421 | 12663542 | Abasia | |
| 126635421 | 12663542 | Anxiety | |
| 126635421 | 12663542 | Arthralgia | |
| 126635421 | 12663542 | Drug dose omission | |
| 126635421 | 12663542 | Pain | |
| 126635421 | 12663542 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |